Augustine Therapeutics

Developer of therapeutics for neuromuscular diseases

placeFlanders, Belgium calendar_todayFounded 2019 groups1 employees language augustinetx.com

Registered entities

Social engagement

Social engagement: 5.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Asabys Partners, V-Bio Ventures, PMV, VIB.

Investor typeCountShare
Venture capital650%
Bank & private debt18%
Other / undisclosed542%

Recent activity

2 Jun 2026
Event
2026 Scientific Sessions of the American Diabetes Association® (ADA)
4 May 2026
Event
Mini-Symposium: HDAC6 Inhibition as a Therapeutic Approach for Neuromuscular Diseases
30 Apr 2026
Event
BioEquity Europe 2026
Coming soon